Global Prime Editing and CRISPR Market is Expected to Reach $23.49 Billion by 2030: Says AMR
July 13, 2021 08:54 ET
|
Allied Market Research
Portland, OR, July 13, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Prime Editing And CRISPR Market was estimated at $2.69 billion in 2020 and is...
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies
June 15, 2021 11:10 ET
|
XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
Shape Memory Polymer Market projected to surpass $1 billion by 2027, Says Global Market Insights Inc.
April 08, 2021 06:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, April 08, 2021 (GLOBE NEWSWIRE) -- Based on Global Market Insights Inc., report, the Shape Memory Polymer Market was estimated at $392.4 million in 2020 and is slated to exceed...
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 29, 2021 08:30 ET
|
XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
Milestone Scientific to Present at the Q1 Virtual Investor Summit
March 12, 2021 07:00 ET
|
Milestone Scientific Inc.
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually...
Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
February 25, 2021 07:00 ET
|
Axovia Therapeutics
Axovia is focused on developing transformative gene therapies for cilia disorders, starting with Bardet-Biedl SyndromeAxovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by...
KEVIN LESLIE NAMED FIRST EXECUTIVE DIRECTOR OF THE HAMPTON ROADS BIOMEDICAL RESEARCH CONSORTIUM
November 17, 2020 08:58 ET
|
Old Dominion University
Norfolk, VA, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Kevin Leslie has been named executive director of the new Hampton Roads Biomedical Research Consortium (HRBRC), a partnership between Old Dominion...
BIOMEDigital to Highlight MedTech’s Leading Companies and Technologies in New Product Tour Feature
October 30, 2020 10:00 ET
|
BioMEDDevice / ESC San Jose
BIOMEDigital announces its New Product Tour lineup of companies showcasing new products exclusive at the event, taking place Nov. 4 and 5.New products announced span medical components designed to...
Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma
October 16, 2020 11:00 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
NeuroSigma Receives Bridge Financing from Checkmate Capital
September 21, 2020 11:00 ET
|
Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...